Skip to main content
Clinical Trials/NCT02594540
NCT02594540CompletedNot Applicable

Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation - A Randomized Clinical Trial

Federal University of Health Science of Porto Alegre2 sites in 1 country28 target enrollmentStarted: December 1, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
28
Locations
2
Primary Endpoint
Kinetic and kinematic gait analysis

Study Overview

Brief Summary

The purpose of this study is to evaluate safety and effectiveness of the peripheral mechanical stimulation of the feet on gait variables, clinical status, risk of falls, BDNF levels, immunological profile and brain functional connectivity changes in patients with Parkinson's disease.

Detailed Description

Patients will be submitted to 8 sessions of peripheral mechanical stimulation of the feet or sham stimulation along 4 weeks.

Evaluations will be performed before and after the first session, after the forth and the eighth session.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
50 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Diagnosis of idiopathic Parkinson's disease based on clinical criteria, dopamine transporter (DaT) scans and/or magnetic resonance imaging;
  • Able to walk 25 feet unassisted or with minimal assistance;
  • Presenting freezing of gait;
  • Aged between 50-85 years;
  • Minimum score of 20 in the Mini Mental State Examination (MMSE);

Exclusion Criteria

  • Secondary musculoskeletal disorder involving the lower limb, as chondral injuries, ligament and ankle sprains which may impede the realization of the gait by pain or motion disability;
  • Peripheral neuropathy;
  • Not attending all the treatment;
  • Absolute contraindications for fMRI (just for fMRI examination);
  • Presence of deep brain stimulation;

Outcomes

Primary Outcomes

Kinetic and kinematic gait analysis

Time Frame: 4 weeks of treatment

Evaluated by means of the 3-D motion analysis system (BTS SMART DX 400).

Secondary Outcomes

  • Symptoms of Parkinson's disease progress(4 weeks of treatment)
  • Serum levels of BDNF(4 weeks of treatment)
  • Cytokine and Cortisol Assessment(4 weeks of treatment)
  • Sensorio-motor connectivity(4 weeks of treatment)
  • Risk of falls(4 weeks of treatment)
  • Motor impairment(4 weeks of treatment)
  • Level of depression(4 weeks of treatment)
  • Lymphocyte Proliferation Assessment(4 weeks of treatment)

Investigators

Sponsor
Federal University of Health Science of Porto Alegre
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Aline de Souza Pagnussat

PhD

Federal University of Health Science of Porto Alegre

Study Sites (2)

Loading locations...

Similar Trials

Effects of the Mechanical Peripheral... | Clinical Trial